Sfoglia per Autore
Expression proteomics of peripheral blood lymphocytes from Parkinson's disease patients
2006-01-01 Mila S; Albo AG; Corpillo D; Zibetti M; Bergamasco B ; Lopiano L ; Fasano M.
Proteomic analysis of dopamine and copper toxicity in SH-SY5Y human neuroblastoma cells expressing alpha-synuclein
2006-01-01 Fasano M; Colapinto M; Mila S; Corpillo D; Bergamasco BB ; Lopiano L.
The proteomic approach in Parkinson's disease.
2007-01-01 M. Fasano;B. Bergamasco;L. Lopiano
Peripheral biomarkers of Parkinson's disease as early reporters of central neurodegeneration.
2008-01-01 M. Fasano;T. Alberio;L. Lopiano
Alpha-synuclein and Parkinson's disease: a proteomic view.
2008-01-01 M. Fasano;L. Lopiano
Proteomics as a tool to investigate cell models for dopamine toxicity
2008-01-01 M. Fasano; T. Alberio; M. Colapinto; S. Mila; L. Lopiano
Lymphocyte proteomics of Parkinson’s disease patients reveals cytosckeletal protein dysregulation and oxidative stress
2009-01-01 S. Mila; A. Giuliano Albo; D. Corpillo; S. Giraudo; M. Zibetti; E. M. Bucci; L. Lopiano; M. Fasano
Thermodynamic analysis of hydration in human serum heme-albumin
2009-01-01 Baroni S; Pariani G; Fanali G; Longo D; Ascenzi P; Aime S; Fasano M
Binding of anti-Parkinson's disease drugs to human serum albumin is allosterically modulated.
2010-01-01 G. Fanali;V. Rampoldi;A. d. Masi;A. Bolli;L. Lopiano;P. Ascenzi;M. Fasano
Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis.
2010-01-01 T. Alberio;A. M. Bossi;A. Milli;E. Parma;M. B. Gariboldi;G. Tosi;L. Lopiano;M. Fasano
Changes in the two-dimensional electrophoresis pattern of the Parkinson's disease related protein DJ-1 in human SH-SY5Y neuroblastoma cells after dopamine treatment.
2010-01-01 T. Alberio;M. Colapinto;M. Natale;R. Ravizza;M. B. Gariboldi;E. M. Bucci;L. Lopiano;M. Fasano
Verification of a Parkinson's disease protein signature in T-lymphocytes by multiple reaction monitoring.
2014-01-01 Alberio T; McMahon K; Cuccurullo M; Gethings LA; Lawless C; Zibetti M; Lopiano L; Vissers JP; Fasano M.
Low noncarbonic buffer power amplifies acute respiratory acid-base disorders in patients with sepsis: An in vitro study
2021-01-01 Langer T.; Brusatori S.; Carlesso E.; Zadek F.; Brambilla P.; Fusarini C.F.; Duska F.; Caironi P.; Gattinoni L.; Fasano M.; Lualdi M.; Alberio T.; Zanella A.; Pesenti A.; Grasselli G.
Shared and Unique Disease Pathways in Amyotrophic Lateral Sclerosis and Parkinson's Disease Unveiled in Peripheral Blood Mononuclear Cells
2023-01-01 Lualdi, Marta; Casale, Federico; Rizzone, Mario Giorgio; Zibetti, Maurizio; Monti, Chiara; Colugnat, Ilaria; Calvo, Andrea; De Marco, Giovanni; Moglia, Cristina; Fuda, Giuseppe; Comi, Cristoforo; Chiò, Adriano; Lopiano, Leonardo; Fasano, Mauro; Alberio, Tiziana
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Expression proteomics of peripheral blood lymphocytes from Parkinson's disease patients | 2006 | Mila S; Albo AG; Corpillo D; Zibetti M; Bergamasco B ; Lopiano L ; Fasano M. | |
| Proteomic analysis of dopamine and copper toxicity in SH-SY5Y human neuroblastoma cells expressing alpha-synuclein | 2006 | Fasano M; Colapinto M; Mila S; Corpillo D; Bergamasco BB ; Lopiano L. | |
| The proteomic approach in Parkinson's disease. | 2007 | M. Fasano;B. Bergamasco;L. Lopiano | |
| Peripheral biomarkers of Parkinson's disease as early reporters of central neurodegeneration. | 2008 | M. Fasano;T. Alberio;L. Lopiano | |
| Alpha-synuclein and Parkinson's disease: a proteomic view. | 2008 | M. Fasano;L. Lopiano | |
| Proteomics as a tool to investigate cell models for dopamine toxicity | 2008 | M. Fasano; T. Alberio; M. Colapinto; S. Mila; L. Lopiano | |
| Lymphocyte proteomics of Parkinson’s disease patients reveals cytosckeletal protein dysregulation and oxidative stress | 2009 | S. Mila; A. Giuliano Albo; D. Corpillo; S. Giraudo; M. Zibetti; E. M. Bucci; L. Lopiano; M. Fasano | |
| Thermodynamic analysis of hydration in human serum heme-albumin | 2009 | Baroni S; Pariani G; Fanali G; Longo D; Ascenzi P; Aime S; Fasano M | |
| Binding of anti-Parkinson's disease drugs to human serum albumin is allosterically modulated. | 2010 | G. Fanali;V. Rampoldi;A. d. Masi;A. Bolli;L. Lopiano;P. Ascenzi;M. Fasano | |
| Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis. | 2010 | T. Alberio;A. M. Bossi;A. Milli;E. Parma;M. B. Gariboldi;G. Tosi;L. Lopiano;M. Fasano | |
| Changes in the two-dimensional electrophoresis pattern of the Parkinson's disease related protein DJ-1 in human SH-SY5Y neuroblastoma cells after dopamine treatment. | 2010 | T. Alberio;M. Colapinto;M. Natale;R. Ravizza;M. B. Gariboldi;E. M. Bucci;L. Lopiano;M. Fasano | |
| Verification of a Parkinson's disease protein signature in T-lymphocytes by multiple reaction monitoring. | 2014 | Alberio T; McMahon K; Cuccurullo M; Gethings LA; Lawless C; Zibetti M; Lopiano L; Vissers JP; Fasano M. | |
| Low noncarbonic buffer power amplifies acute respiratory acid-base disorders in patients with sepsis: An in vitro study | 2021 | Langer T.; Brusatori S.; Carlesso E.; Zadek F.; Brambilla P.; Fusarini C.F.; Duska F.; Caironi P.; Gattinoni L.; Fasano M.; Lualdi M.; Alberio T.; Zanella A.; Pesenti A.; Grasselli G. | |
| Shared and Unique Disease Pathways in Amyotrophic Lateral Sclerosis and Parkinson's Disease Unveiled in Peripheral Blood Mononuclear Cells | 2023 | Lualdi, Marta; Casale, Federico; Rizzone, Mario Giorgio; Zibetti, Maurizio; Monti, Chiara; Colugnat, Ilaria; Calvo, Andrea; De Marco, Giovanni; Moglia, Cristina; Fuda, Giuseppe; Comi, Cristoforo; Chiò, Adriano; Lopiano, Leonardo; Fasano, Mauro; Alberio, Tiziana |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile